Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Shares Issued (2018 - 2025)

Dianthus Therapeutics (DNTH) has 6 years of Shares Issued data on record, last reported at $187000.0 in Q3 2025.

  • For Q3 2025, Shares Issued changed N/A year-over-year to $187000.0; the TTM value through Sep 2025 reached $39.5 million, up 790420.0%, while the annual FY2024 figure was $39.2 million, N/A changed from the prior year.
  • Shares Issued reached $187000.0 in Q3 2025 per DNTH's latest filing, up from $98000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $39.2 million in Q4 2024 and bottomed at -$514000.0 in Q2 2022.
  • Average Shares Issued over 4 years is $3.9 million, with a median of $18000.0 recorded in 2023.
  • Peak YoY movement for Shares Issued: soared 784100.0% in 2024, then tumbled 88.56% in 2025.
  • A 4-year view of Shares Issued shows it stood at -$49000.0 in 2022, then skyrocketed by 89.8% to -$5000.0 in 2023, then skyrocketed by 784100.0% to $39.2 million in 2024, then crashed by 99.52% to $187000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $187000.0 in Q3 2025, $98000.0 in Q2 2025, and $31000.0 in Q1 2025.